[1] Grothe C, Taminato M, Belasco A, et al. Prophylactic treatment of chronic renal disease in patients undergoing peritoneal dialysis and colonized by Staphylococcus aureus:A systematic review and meta-analysis[J]. BMC Nephrol, 2016, 17(1):115.
[2] Melehani J H, Duncan J A. Inflammasome activation can mediate tissue-specific pathogenesis or protection in Staphylococcus aureus infection[J]. Curr Top Microbiol Immunol, 2016, 397:257-282.
[3] Kobayashi S D, Malachowa N, DeLeo F R. Pathogenesis of Staphylococcus aureus abscesses[J]. Am J Pathol,2015,185(6):1518-1527.
[4] Barkema H W, Schukken Y H, Zadoks R N. Invited review:The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis[J]. J Dairy Sci,2006, 89(6):1877-1895.
[5] Althaqafi A O, Matar M J, Moghnieh R, et al. Burden of methicillin-resistant Staphylococcus aureus pneumonia among hospitalized patients in Lebanon and Saudi Arabia[J]. Infect Drug Resist, 2017, 10:49-55.
[6] 李娟. 牛源金黄色葡萄球菌耐药现状及药敏检测方法探讨[J]. 中国畜牧兽医, 2017, 33(3):64.
[7] Choo E J, Chambers H F. Treatment of methicillin-resistant Staphylococcus aureus bacteremia[J]. Infect Chemother, 2016, 48(4):267-273.
[8] Sowash M G, Uhlemann A C. Community-associated methicillin-resistant Staphylococcus aureus case studies[J]. Methods Mol Biol,2014,1085:25-69.
[9] Blanco N, Perencevich E, Li S S,et al. Effect of meteorological factors and geographic location on methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in the US[J]. PLoS One,2017,12(5):e0178254.
[10] Hu Q, Peng H, Rao X.Molecular events for promotion of vancomycin resistance in vancomycin intermediate Staphylococcus aureus[J]. Front Microbiol,2016,7:1601.
[11] Liu Q, Du X, Hong X, et al. Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection[J]. Infect Immun,2015,83(5):2168-2174.
[12] Delfani S, Mohabati M A, Imani F A A, et al. Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate[J]. Med Microbiol Immunol, 2016, 205(1):47-55.
[13] Pietrocola G, Nobile G, Rindi S, et al.Staphylococcus aureus manipulates innate immunity through own and host-expressed proteases[J]. Front Cell Infect Microbiol,2017,7:166.
[14] Jusko M, Potempa J, Kantyka T, et al. Staphylococcal proteases aid in evasion of the human complement system[J]. J Innate Immun, 2014,6(1):31-46.
[15] Kim H K, Thammavongsa V, Schneewind O, et al. Recurrent infections and immune evasion strategies of Staphylococcus aureus[J]. Curr Opin Microbiol, 2012, 15(1):92-99.
[16] Josefsson E, Hartford O, O'Brien L, et al. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant[J]. J Infect Dis, 2001, 184(12):1572-1580.
[17] 冯昊, 刘乐锋, 迟佳琦, 等. 金黄色葡萄球菌凝集因子A的免疫原性[J]. 生物工程学报, 2009, 25(8):1180-1186.
[18] Schaffer A C, Solinga R M, Cocchiaro J, et al. Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model[J]. Infect Immun, 2006, 74(4):2145-2153.
[19] Kuklin N A, Clark D J, Secore S, et al. A novel Staphylococcus aureus vaccine:Iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model[J]. Infect Immun, 2006, 74(4):2215-2223.
[20] Yu L,Fan Z,Ma J,et al.Cross-protective effect of a novel multi-antigen-chimeric vaccine against Streptococcus and Staphylococcus aureus infection in mice[J]. J Med Microbiol, 2014,63(Pt12):1732-1740.
[21] Meza-Sánchez D, Pérez-Montesinos G, Sánchez-García J, et al. Intradermal immunization in the ear with cholera toxin and its non-toxic β subunit promotes efficient Th1 and Th17 differentiation dependent on migrating DCs[J].Eur J Immunol, 2011, 41(10):2894-2904.
[22] Lee J B,Jang J E,Song M K,et al. Intranasal delivery of cholera toxin induces th17-dominated T-cell response to by stander antigens[J]. PLoS One, 2009, 4(4):e5190.
[23] Lin L, Ibrahim A S, Xu X, et al. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice[J]. PLoS Pathog, 2009, 5(12):e1000703.
[24] Montgomery C P, Daniels M, Zhao F, et al. Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A[J]. Infect Immun,2014, 82(5):2125-2134. |